Answers are grounded in this paper and cite their sources.
Observational analysis evaluates dosage associations for botulinum neurotoxin in blepharospasm and hemifacial spasm, indicating potential treatment insights.
Purpose The purpose of this study is to evaluate the association between the blepharospasm disability index (BSDI) and botulinum neurotoxin (BTX) dosage for patients affected by either benign essential blepharospasm or hemifacial spasm.
No takes yet. Share an insight, caveat, or question.
Shirriff et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: